Federal award (DELIVERY ORDER, fiscal year 2023)
Recipient: AMERISOURCEBERGEN DRUG CORP
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2024-03-22 to 2024-03-25
Current total value of award: $6561.62
Description: 4564050221!QUILLIVANT XR ORAL SUSP 60ML 5MG/ML